Phase 4 IOP Signals Associated With ILUVIEN®
(PALADIN Trial)
Recruiting in Palo Alto (17 mi)
+40 other locations
Age: Any Age
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Phase 4
Waitlist Available
Sponsor: Alimera Sciences
No Placebo Group
Prior Safety Data
Trial Summary
What is the purpose of this trial?
This study will assess the safety in patients treated with ILUVIEN, with primary focus on IOP.
Eligibility Criteria
Inclusion Criteria
Patients who are eligible for treatment with ILUVIEN based on the Prescribing Information.
Treatment Details
Interventions
- ILUVIEN 0.19 MG (Corticosteroid)
Participant Groups
1Treatment groups
Experimental Treatment
Group I: ILUVIEN 0.19 MGExperimental Treatment1 Intervention
All patients will receive ILUVIEN (Fluocinolone Acetonide Intravitreal Insert) 0.19 mg.
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Laurel Eye ClinicBrookville, PA
Orange County Retina Medical GroupSanta Ana, CA
Atlantis Eye CareHuntington Beach, CA
Paducah Retinal CenterPaducah, KY
More Trial Locations
Loading ...
Who Is Running the Clinical Trial?
Alimera SciencesLead Sponsor